Quarterlytics / Financial Services / Asset Management / Sopheon Plc / FY1998 Annual Report

Sopheon Plc
Annual Report 1998

SPE · LSE Financial Services
Claim this profile
Ticker SPE
Exchange LSE
Sector Financial Services
Industry Asset Management
Employees 51-200
← All annual reports
FY1998 Annual Report · Sopheon Plc
Loading PDF…
ANNUAL REPORT 1998

Controlling the production and flow of
business knowledge is similar to the
management of water: high quality,
immediate availability and crystal clarity in
a cost effective manner must be ensured.

CONTENTS POLYDOC PLC ANNUAL REPORT 1998

3

4

6

10

11

12

13

14

16

16

22

24

25

26

27

28

29

30

42

Company Profile

Chairman’s Statement

Market and Business Update

Product Development

Summary

PolyDoc’s Business Values

Financial Report

Directors and Advisers

Financial Highlights

Directors’ Report

Report on Directors’ Remuneration

Statement of Directors’ Responsibilities

Group Profit and Loss Account

Group Statement of Total Recognised Gains and Losses

Group Balance Sheet

Company Balance Sheet

Group Statement of Cash Flows

Notes to the Accounts

Auditors’ Report to the Shareholders of PolyDoc Plc

2

        
        
COMPANY PROFILE

PolyDoc  is  an  internationally  orientated  company  specialising  in  the  development  and
provision of business solutions in the rapidly emerging field of Knowledge Management with
specific  focus  on  the  health  care,  manufacturing  and  defence  sectors.  PolyDoc’s  business
solutions  significantly  enhance  productivity  and  quality  in  text-based  knowledge  production
areas as well as enabling the re-use of knowledge throughout the customer organisation. The
major  element  of  each  solution  is  one  or  more  of  PolyDoc’s  computer  software  products,
enhanced  and  customised  for  each  individual  customer,  integrating  into  their  existing  or
planned  Intranet,  Internet  and  general  Web-based  environment.  The  company’s  software
assets include a number of leading edge core components and toolkits that are used to create
customised  software  application  products.  PolyDoc’s  development  centres  are  based  in  The
Netherlands  (Amsterdam  and  Maastricht).  It  has  direct  sales  operations  in  the  United
Kingdom,
The Netherlands and the United States, and is also establishing indirect sales and marketing
activities through business partners in each of these territories. Other European countries and
the Pacific Rim will follow thereafter. PolyDoc Plc is registered in London, United Kingdom
and  has  its  central  office  in  Amsterdam,  The  Netherlands.  The  ordinary  shares  of  PolyDoc
Plc are publicly traded on the Alternative Investment Market (‘AIM’) of The London Stock
Exchange, and on the New Market of the Amsterdam Exchanges (‘NMAX’).

3

        
        
CHAIRMAN’S STATEMENT

Our  objective  is  to  be  a  company  with  a  unique  group  of  software  products  based  on
linguistic approaches and methodologies and language management technologies so that we
may  be  at  the  leading  edge  of  the  Knowledge  Management  market.  I  believe  that  1998  has
been  a  very  successful  year  in  our  development  in  that  we  have  established  a  more
substantial customer base with an installed range of products, which will provide a platform
for us to build upon in the next important stage of the company’s growth.

The Knowledge Management market is a relatively new market where I think PolyDoc is a
pioneer  in  what  is  undoubtedly  one  of  the  most  rapidly  growing  markets  in  the  world  of
modern technology. The massive growth in Internet and Intranet usage is fuelling the critical
need to manage knowledge and information in a structured and comprehensive manner.

I  have  indicated  previously  that  generally  the  difficulties  in  forecasting  in  such  a  new  area
were more a matter of timing than quality or pricing and 1998 has continued to show this to
be the case.

FINANCIAL RESULTS

Revenue from business based on QualiFlow, our health care industry product, has started to
build,  contributing  to  an  increase  in  total  turnover  of  more  than  300%  compared  to  the
previous year. With operating costs running at a similar level also compared to the previous
year  this  has  resulted  in  an  important  reduction  in  pre-tax  losses  to  £981,000.  These
improvements  are  mainly  due  to  the  development  of  the  revenue  stream  contracted  early  in
the  year  in  the  health  care  industry  and  the  continuing  pilot  work  in  the  defence  industry
coupled  with  well-controlled  operating  costs.  We  would  have  hoped  to  see  an  even  greater
reduction  in  these  losses.  However  as  I  have  previously  stated,  the  early  adopters  of  our
products have taken longer to establish than anticipated.

OUTLOOK FOR 1999 AND 2000

The recognition and emphasis on the implementation of Knowledge Management approaches
and  solutions  as  a  major  contributor  to  the  bottom  line  of  most  organisations  continues  to
increase and appears to have entered an essential phase. Many businesses have now allocated
significant specific budgets for helping to deal with the problems of information overload and
the additional competitive pressures on their business where valuable knowledge (intellectual
capital)  can  truly  be  leveraged.  We  expect  to  see  an  important  shift  in  the  market  now  as
many  companies  move  from  a  planning  to  an  implementation  mode,  from  ‘talking’  to
‘buying’ as far as PolyDoc’s solutions are concerned.

Pro-GRAM  BV  a  joint  venture  company,  has  been  formed  by  three  academic/  teaching
hospitals in The Netherlands to market, together with PolyDoc, the QualiFlow software and
the  knowledge  created  using  the  software  to  a  broad  range  of  organisations  in  the  Dutch
health  care  industry.  PolyDoc  has  accepted  an  invitation  to  become  a  shareholder  in  this
company.  With  our  health  care  solution  implementations  now  rapidly  leading  us  to  having

4

        
        
referenceable  customers,  joint  marketing  activities  commenced  at  the  beginning  of  1999.
These  developments  have  already  received  some  enthusiastic  press  coverage  in  The
Netherlands  during  March  1999.  This  joint  venture  company  is  ideally  placed  to  accelerate
our  QualiFlow  and  Lessenger  sales  in  the  Benelux.  With  more  than  one  hundred  potential
prospects  for  these  solutions  coupled  with  the  backing  and  credibility  of  the  top  leading
hospitals, we are confident of achieving good sales success in 1999 and beyond.

In  the  UK,  The  Netherlands  and  the  USA  the  further  partnerships  now  being  established,
together with the several others under discussion, also give us great confidence of achieving
important  customer  and  revenue  developments  in  these  territories.  This  combined  with  the
increased  marketing  of  our  NormFlow  manufacturing  solution  and  the  firm  position  we
expect to establish in the UK defence industry should make 1999 another year of significant
revenue growth. It is also expected to firmly place us in each of our target geographies with
distinct and strong industry lines of business: Health care, Defence and Manufacturing. With
a comprehensive and solid group of partners being further developed and grown throughout
1999,  the  year  2000  should  see  PolyDoc  firmly  on  the  rapid  growth  curve  for  the  coming
years.

CAPITAL RAISING DEVELOPMENTS

I  was  pleased  to  announce  that  we  completed  the  raising  of  an  additional  £1.57  million  of
interim funding in the form of a convertible loan in July 1998 and a further £0.5 million from
the issue of ordinary shares in March this year, and the subsequent extension in April of this
year, of the repayment or conversion of the convertible loan from its original date of 31 July
1999 to 31 July 2000. These funds are for interim working capital and to enable us to commit
to  the  joint  venture  mentioned  in  the  health  care  section  of  this  statement.  We  also  issued
68,500  ordinary  shares  to  cover  the  cash  consideration  in  the  acquisition  of  Lessenger
Associates BV in December 1998. For the longer term we plan to complete a further, more
substantial  fund  raising  later  in  this  current  year.  This  will  ensure  that  we  have  the  cash  in
place to meet our ongoing financial requirements, and to build upon our business successes in
the  Health  care  industry,  by  expanding  into  the  UK  and  USA  markets,  replicating  the
successful formula we have developed in The Netherlands. Additionally, we will then be in a
position  to  more  fully  exploit  our  potential  in  the  lucrative  Defence  and  Manufacturing
industries,  where  we  are  currently  working  with  our  initial  customers  as  also  mentioned
earlier in this statement. With the above mentioned developments I feel we have now arrived
at  the  next  major  stage  in  the  development  of  PolyDoc.  It  continues  to  be  our  objective  to
become  a  major  player  in  the  burgeoning  Knowledge  Management  industry  and  with  that
clearly in our minds we have been putting together our business plans through to the end of
the  year  2000.  With  our  sights  set  on  giving  our  shareholders  the  returns  that  are  clearly
available  in  our  market  we  also  announced  the  appointment  of  Durlacher  Ltd  as  the
company’s Nominated Broker alongside Bell Lawrie Wise Speke the company’s Nominated
Adviser. Durlacher has a very strong technology research division which has researched and
published extensively on the Knowledge Management industry.

5

        
        
SUMMARY

1998  has  shown  to  be  a  turning  point  for  PolyDoc  both  in  terms  of  significant  increase  in
revenues  and  the  establishment  of  a  solid  commercial  base  of  customers  and  references.
Simultaneously,  our  vision  of  a  substantial  market  for  knowledge  and  content  management
predicted  at  PolyDoc’s  inception  five  years  ago  has  finally  become  reality,  and  we  have  a
clearly defined position* within it. With our unique approach and products we are poised for
major growth in the coming years. This year should see continued growth, in particular in our
established health care division where we have our core base of major clients and our newly
acquired base of over fifty new customers to build upon. We will also continue to invest in
our  Defence  and  Manufacturing  industry  product  offerings  as  we  work  with  our  initial
customers in those markets to replicate the ‘proof of business concept’ we have achieved in
the Health care sector. By raising further capital we will be able to significantly expand our
sales, marketing and partner efforts especially into the very sizeable UK and USA markets. It
will  enable  us  to  invest  in  developing  our  relationships  with  both  our  current  and  future
customers  and  business  partners  resulting  in  our  bringing  ever  improving  products  to  our
existing markets and beyond. I would very much like to thank everyone within PolyDoc who
has  worked  so  hard  during  the  year.  I  am  extremely  proud  of  our  achievements  in  dealing
with so many challenges and in laying the foundations for us to have the opportunity of being
at the leading edge of the Knowledge Management market.

Barry Mence,
Executive Chairman.

* Visit our Website: http://www.polydoc.com

6

        
        
These  quotations  from  some  of  the  most  recent  Business  Strategy  and
to  PolyDoc
Knowledge  Management  surveys  are  of  vital 
importance 
stakeholders  be 
future)  customers,  shareholders  or
employees.

they  (current  and 

“Corporate spend on KM (Knowledge Management) is expected to rise to 5,5% of revenues
in three years.”

Cranfield School of Management

“95% of chief executives see knowledge management as an essential ingredient for the
success of their company.”

Recent Price Waterhouse Coopers survey

“The best knowledge management technology is provided by small specialist companies.”

Recent Financial Times (KM) supplement

“To exploit the technology, users need an integrated architecture.”

Knowledge Management by research specialist Ovum

7

        
        
MARKET AND BUSINESS UPDATE

There is in each of these quotations, and many other popular Knowledge Management
industry views, an essential factor contributing to the near term realisation of PolyDoc’s
potential.

“Corporate spend heading towards 5,5% of revenues”:
After  a  frustrating  period  of  much  interest  and  formulation  of  plansby  our  prospective
customers,  organisations  are  finally  starting  to  allocate  and  spend  significant  budgets  to
resolve critical business issues.

“Most CEO’s see KM as essential”:
The business issues that PolyDoc  addressses have the attention and commitment
to resolution of top management, the best guarantee for action.

“Best KM technology comes from specialist companies”:
As a pioneer in the field of KM software, utilising the latest generic development technology
from  leading  firms  like  Microsoft®  and  Oracle®  PolyDoc  is  a  specialist  KM  technology
developer with recently proven technology.

“Users need an integrated architecture”:
Since its foundation five years ago, initially primarily as a research and development group,
PolyDoc  has  been  developing  its  software  following  its  proprietary  methodology  and
architecture “Integrated Document Production Architecture (IDP/A).

So  PolyDoc  is  unquestionably  positioned  in  an  exciting  sector  of  the  software  marketplace
where  customer  buying  activity  is  now  starting  to  accelerate.  Our  own  marketplace
experience  from  customers  and  prospects,  combined  with  much  research,  has  shown  that  in
addition  to  integrated  solutions,  organisations  are  demanding  comprehensive  industry-
specific business solutions. For this reason PolyDoc has started to specialise on a focused set
of industries where KM solutions are at the top of the business agenda: Health care, Defence
and  Manufacturing.  These  markets  are  being  addressed  by  both  PolyDoc  and  our  planned
business  partners,  two  of  which  have  recently  entered  marketing  agreements  with  PolyDoc,
one in the UK and the other in the USA. Additional partnerships are being developed both for
the  current  target  markets  as  well  as  other  potentially  lucrative  sectors.  This  realisation  of
partnerships,  in  line  with  PolyDoc’s  consistently  stated  business  strategy,  together  with  the
recent  formation  of  our  consulting  division  is  expected  to  help  speed  up  the  sales  cycles  of
PolyDoc’s products.

Health care

At the end of the first quarter 1998 we signed our first multimillion guilder contract involving
three  (from  a  total  of  eight)  academic/teaching  hospitals  in  The  Netherlands.  Fulfilment  of
this  contract,  and  the  further  development  of  our  QualiFlow  health  care  solution,  is
proceeding  according  to  plan  and  the  other  academic  hospitals  as  well  as  several  general
hospitals are showing keen interest. We currently expect to sign further substantial business
in this area during the current year, as we seek to establish our approach as a form of standard
for the Dutch health care industry.

8

        
        
As  mentioned  earlier  in  this  document,  a  joint  venture  company  called  Pro-GRAM  BV  has
been  formed  by  the  initial  academic  hospitals  to  market,  together  with  PolyDoc,  the
QualiFlow  software  and  the  knowledge  created  using  the  software  to  a  broad  range  of
organisations  in  the  Dutch  health  care  industry.  PolyDoc  has  accepted  an  invitation  to
become  a  shareholder  in  this  company,  which  has  commenced  active  marketing  at  the
beginning  of  1999  and  has  already  received  some  enthusiastic  press  coverage  in  The
Netherlands during March 1999.

Another  health  care  business  development  is  the  completion  of  the  purchase  of  Lessenger
Associates  B.V.,  a  small  Dutch-based  software  developer  and  supplier  to  the  health  care
industry.  Their  products  are  mature  and  well  established  in  7  academic  hospitals  and  more
than  50  regional  and  general  hospitals  in  The  Netherlands,  as  well  as  a  number  of  large
companies outside the hospital sector. In addition to our commitment to support the existing
products, we have now started the process that will both add important new functionality to
the  Lessenger  products  as  well  as  ensuring  integration  of  the  Lessenger  family  with  our
QualiFlow  health  care  solution.  This  should  put  both  PolyDoc  and  Pro-GRAM  in  an  even
stronger position to further accelerate product sales into the substantial health care market - in
fact new Lessenger product sales have already been contracted in the first quarter of 1999.

Defence

The  StudyFlow  pilot  executed  at  DERA,  the  Defence  Evaluation  and  Research  Agency
related  to  the  UK  Ministry  of  Defence,  was  successfully  evaluated  to  be  able  to  start  work
with  the  agency  on  the  final  stages  of  justification  for  the  implementation  and  roll  out  of  a
full production PolyDoc system. This contracted work is expected to be concluded in the first
half of 1999. Our strategy for penetrating the Defence Industry has also evolved further and a
major  defence  industry  manufacturer  has  expanded  the  process  for  evaluating  the
implementation and benefits of PolyDoc’s solutions.

Manufacturing

DSM, the multinational chemical manufacturer, has gone into full production with the latest
version (3.0) of NormFlow, our solution for the production and maintenance of standards for
the manufacturing and process industries. We have been requested to further extend the scope
and  use  of  the  product  at  DSM  resulting  in  additional  revenue  on  top  of  the  ongoing
maintenance fees. Further development and volume selling of this new enhanced NormFlow
is presently underway, and we would expect to see the commercial results of this during the
current year.

9

        
        
Business Partnerships

Our  strategy  for  expanding  PolyDoc’s  business  into  volume  sales  has  always  been  to  enter
into  business  partnerships  with  mature  organisations  with  strong  customer  bases,  once  we
have established the  early customers in our chosen  industries.  The  initial  target  geographies
remain the Benelux countries, the UK and the USA. In The Netherlands we have entered an
agreement  with  KPMG  to  work  together  with  them  at  one  of  their  major  clients  on  an
important  Knowledge  Management  project.  When  this  work  is  successfully  completed  we
would  expect  this  to  lead    to  a  broader  arrangement  involving  more  clients  and  PolyDoc’s
software products. In addition to the new partnership covering the Benelux with the hospitals’
joint venture company, Pro-GRAM, we have recently put a non-exclusive agreement in place
with our first full business partner in the United Kingdom. Marlow Consulting, specialising
in  management  consultancy  and  systems  integration,  will  be  focusing  with  PolyDoc’s
products on a number of named accounts in the health care and pharmaceutical industries.

Another  recent  partnership  signing  will  be  instrumental  in  helping  PolyDoc  enter  the  North
American  marketplace.  Teltech  Corporation  is  a  leader  in  the  Knowledge  Management
industry  providing  its  products,  mainly  content  management  services  and  information
research,  to  half  of  the  Fortune  500.  Under  the  terms  of  the  agreement  Teltech  will  market
PolyDoc software as part of its own solution selling throughout the United States.

Consultancy Services

As often happens when marketing software products, during the past couple of years we have
been increasingly requested by our customers and prospects to provide them with services in
specific  areas  of  Knowledge  and  Content  Management.  In  order  to  capitalise  more  fully  on
these opportunities we have recently formed a Consultancy Services group which is focussed
on generating additional revenues, as well as bringing potential Software products customers
into  PolyDoc  as  paying  Services  customers.  As  our  business  in  these  areas  grows  we  will
then be recruiting additional staff this year specifically for this services group.

1998  has  seen  good  revenue  growth  and  a  major  increase  in  the  customer  base  with  the
Lessenger  acquisition  bringing  the  number  of  customers  to  over  seventy  companies  and
organisations.  This  has  now  given  rise  to  significant  revenue  opportunities  with  these  and
many other organisations in 1999 and beyond, such as the multimillion guilder order placed
by  three  leading  hospitals  in  The  Netherlands  and  announced  by  PolyDoc  in  March  1998.
These  new  customers  will  all  be  taking  advantage  of  the  important  progress  PolyDoc’s
software  development  group  has  made  during  the  course  of  the  year.  Our  latest  generation
core  software  (called  XFlow),  which  is  the  basis  of  all  of  PolyDoc’s  solutions,  has  put  the
company  into  the  leading  group  of  software  product  developers  in  the  rapidly  accelerating
Knowledge Management market.

In  the  geographies  where  we  are  focusing  the  majority  of  our  efforts  –  Benelux,  United
Kingdom,  USA  –  we  expect  to  report  significant  progress  during  1999  in  business
partnerships as well as achieving solid commercial success with our own direct sales efforts.

10

        
        
PRODUCT DEVELOPMENT

During  the  course  of  1998  PolyDoc’s  product  development,  support  and  implementation
groups achieved a number of important milestones:

§  Development  and  delivery  of  software  destined  for  production  usage  in  large

organisational environments.

§ 

Implementation  of  a  focused  Health  care  division  concentrating  on  delivery,
implementation and marketing of PolyDoc’s health care applications.

§  Establishment of a customer-satisfaction oriented Helpdesk to support both the increasing
number  of  new  PolyDoc  users  as  well  as  the  recently  acquired  customer  base  of  more
than 70 users of Lessenger software.

§  Commencement  of  the  process  to  fully  integrate  products  from  generic  technology
software  market  leaders  such  as  Microsoft®,  Oracle®  and  Lotus®  into  PolyDoc’s
development approach and customer application solutions.

These  and  other  achievements  have  clearly  started  to  demonstrate  PolyDoc’s  position  as  a
professional supplier of proven technologies for important production environments in large
organisations.  The  main  core  component  of  PolyDoc’s  advanced  software  solutions,  called
XFlow, has obtained significant advancements in demonstrating its robustness and flexibility,
and  continues  to  place  PolyDoc  in  the  leading  pack  of  specialist  Knowledge  Management
technology providers. With the realisation of version 3 of our XFlow software, together with
our  unique  TermFlow  component,  we  and  our  partners  can  provide  customisable,  practical
and implementable solutions in line with PolyDoc’s consistently stated business strategy.

As  one  of  the  first  software  developers  to  encompass  Web-based  publishing,  PolyDoc  has
always  kept  abreast  of  Internet  and  Intranet  technologies  which  are,  by  definition  as
collaborative  tools,  key  elements  in  the  adoption  of  Knowledge  Management  software  as
solutions  for  critical  business  issues.  With  this  in  mind,  development  of  our  next  version  of
the  core  software,  XFlow  version  4,  is  well  underway  and  we  anticipate  availability  of
software based on this next advancement to begin early in the year 2000.

Key  to  any  software  production  environment  are  people,  processes  and  technology.  On  the
latter  issue,  as  mentioned  above,  PolyDoc  is  currently  active  to  further  integrate  industry
standard  technology  into  its  advanced  application  solutions.  With  regard  to  process,  we  are
making  good  progress  with  the  implementation  of  a  comprehensive  Quality  Management
approach  to  organising  and  managing  all  parts  of  our  business,  with  extra  emphasis  on  the
core of our activities in software development, production and delivery  And  with respect to
people we are pleased to report that we are in the fortunate position both to have retained all
of our key initial innovative research and development staff and to have started to attract key
individuals from recognised software industry achievers to join the PolyDoc team.

11

        
        
As  reported  last  year,  we  were  very  pleased  to  receive  the  prestigious  Eureka  status  for  a
successive  three  year  period.  Now  into  its  second  year  of  this  period’s  funding  through  the
Eureka  channels,  one  of  PolyDoc’s  research  projects  (ITMC  –  Integrated  Terminology
Management  Cycle)  continued  to  make  good  progress  both  in  terms  of  general  innovation
and  in  the  demonstration  of  its  capabilities  when  applied  in  marketplace  environments.  We
look  forward  also  to  continued  progress  in  this  area  during  the  current  year  and  to
maintaining  the  international  recognition  for  our  innovative  concepts  and  development
approach.

Summary

During  1998  PolyDoc  has  made  good  progress  both  in  terms  of  a  significant  increase  in
revenues  and  the  establishment  of  a  solid  commercial  base  of  customers  and  references.
Simultaneously,  our  vision  of  a  substantial  market  for  knowledge  and  content  management
predicted  at  PolyDoc’s  inception  five  years  ago  has  finally  become  reality,  and  we  have  a
clearly defined position* within it. With our unique approach and products we are poised for
major growth in the coming years. This year should see continued growth, in particular in our
established health care division where we have our core base of major clients and our newly
acquired base of over fifty new customers to build upon. We will also continue to invest in
our  Defence  and  Manufacturing  industry  product  offerings  as  we  work  with  our  initial
customers in those markets to replicate the ‘proof of business concept’ we have achieved in
the Health care sector. This should make 1999 a year of continued revenue growth and ensure
the further establishment of a solid commercial track record.

* visit our Website: http://www.polydoc.com

12

        
        
POLYDOC’S BUSINESS VALUES

The set of values by which PolyDoc operates its business activities and our employees
constantly strive to express are encapsulated in the following four statements.

Customers:
To  measurably  enhance  our  customers’  business  performance,  by  implementing  pragmatic,
quality-driven  solutions  of  our  knowledge  management  innovations  as  part  of  a  long-term
relationship and commitment to service.

Shareholders:
To  increase  shareholder  value  by  globally  growing  our  customer  and  revenue  base  in  a
manner  which  constantly  improves  our  profitability,  both  through  our  own  commercial
efforts and those of business partners.

Employees:
To  encourage  personal  contribution,  creative  interaction,  open  communication  and  skills
improvement  and  to  provide  a  challenging  and  stimulating  team  oriented  environment
enabling  the  recruitment  and  long-term  retention  of  flexible,  self-motivating,  high-calibre
professionals.

Marketplace:
To  maintain  a  leading  international  position  in  the  Knowledge  Management  market  by
reinforcing existing solutions and to continue innovating in the field of language management
applied to business performance improvement.

13

        
        
FINANCIAL REPORT

14

        
        
DIRECTORS AND ADVISERS

Directors

Barry K. Mence,            Executive Chairman
Richard V. Maddocks,   BSc, Managing Director
Huub J.M. Rutten,         Drs., Director
E.R.E. Iljitsj Wiebenga, C.A. (S.A.), Finance Director
Hans Coltof,                  Dr., Non Executive Director
Stuart A. Silcock,           FCA, Non Executive Director
David C. Geest,             Non Executive Director,
                                       (resigned 31 December 1998)

Secretary

E.R.E. Iljitsj Wiebenga, C.A. (S.A.)

Registered office

18 Southampton Place
London WC1A 2AJ

Registered number

Registered in England and Wales: 3217859

Auditors

Ernst & Young
Apex Plaza
Reading RG1 1YE

Principal banker

Rabobank Amsterdam b.a.
Wilhelminaplantsoen 124
1111 CP Diemen The Netherlands

Solicitors

Lloyds Bank Plc
77 High Street
Southend-on Sea
Essex SS1 1HT

Edge Ellison
18 Southampton Place
London WC1A 2AJ

Nauta Dutilh
Prinses Irenestraat 59
1077 WV Amsterdam
The Netherlands

Nominated adviser

Bell Lawrie Wise Speke.
(a division of Brewin Dolphin Securities Limited)
48 St. Vincent Street
Glasgow G2 5TS

Nominated broker

Durlacher Limited
4 Chiswell Street
London EC1Y 4UP

15

        
        
Sponsor

Registrars

(‘NMAX’)
Rabo Securities NV
Amstelplein 1
1090 GP Amsterdam
The Netherlands

(‘AIM’)
Independent Registrars Group Limited
Balfour House 390/398 High Road
Ilford
Essex IG1 1NQ

16

        
        
FINANCIAL HIGHLIGHTS

Group profit and loss account for  the years ended 31 December

1998
£’000  

891
(892)

(1)
(502)
(468)
29

(942)
13
(52)
(981)
(5.2p)

1997
£’000

241
(993)

(752)
(484)
(467)
136

(1.567) 
46
(6)
(1.527) 
(8.2p)  

Description

Turnover
Cost of sales

Gross loss
Sales & marketing expenses
Administrative expenses
Other operating income - foreign exchange gains

Operating loss
Bank interest receivable
Interest payable and similar charges
Loss on ordinary activities before and after taxation
Loss per share -basic and diluted (pence)

17

        
        
 
 
 
 
 
 
 
 
 
 
 
DIRECTORS’ REPORT

Financial Results

The  result  for  the  year  ended  31  December  1998  both  before  and  after  taxation  is  a  loss  of
£981.000  (1997:  £1.527.000)  on  a  turnover  of  £  891.000(1997:£241.000).The  directors  do
not propose to declare a dividend.

Review of the Business

Revenue from business based on QualiFlow, our health care industry product, has started to
build,  contributing  to  an  increase  in  total  turnover  of  more  than  300%  compared  to  the
previous year. With operating costs running at a similar level also compared to the previous
year  this  has  resulted  in  an  important  reduction  in  pre-tax  losses  to  £981.000.  These
improvements  are  mainly  due  to  the  development  of  the  revenue  stream  contracted  early  in
the  year  in  the  health  care  industry  and  the  continuing  pilot  work  in  the  defence  industry
coupled  with  well-controlled  operating  costs.  We  would  have  hoped  to  see  an  even  greater
reduction  in  these  losses.  However  as  we  have  previously  stated  the  early  adopters  of  our
products have taken longer to establish than anticipated.

PolyDoc  continues  to  be  a  technology  driven  company  operating  in  the  Knowledge
Management market and has a growing asset base consisting of many software components
and methodologies. The Board considers PolyDoc to have a unique product formula based on
linguistic approaches and methodologies and language management technologies. It provides
a  bridge  between  the  providers  (and  “inputers”)  of  knowledge  and  the  technology  already
used  by  the  knowledge  users/seekers  to  access  and  retrieve  knowledge.  Simply  stated,
PolyDoc  provides  the  ability  to  capture,  structure,  codify  publish  and  reuse  text-based
knowledge.

Within the knowledge management market, PolyDoc research indicates that it is currently the
only  company  offering  centralised  harmonisation  of  language  and  knowledge  capture
mechanisms  to  enable  the  structuring  and  codification  of  text-based  knowledge  production.
Market  research  shows  that  this  is  an  area  where  customers  are  now  increasingly  seeking
solutions.

PolyDoc’s  business  solutions  significantly  enhance  productivity  and  quality  in  text-based
knowledge  production  areas  as  well  as  enabling  the  re-use  of  knowledge  throughout  the
customer organisation. With these issues now being high on the list to be solved of most large
companies, the future for PolyDoc’s business appears better than ever.

18

        
        
Future Developments

PolyDoc sees its future in the further development and marketing of its following products:

§  QualiFlow In hospitals and health care organisations. Reference is made in the

Chairman’s Statement to Pro-GRAM BV a joint venture company formed by three
academic/teaching hospitals in The Netherlands to market, together with PolyDoc, the
QualiFlow software and the knowledge created. PolyDoc has accepted an invitation to
become a shareholder in this company.

§  ResearchFlow In any large manufacturing organisation, including pharmaceutical and

high technology companies, as well as any research organisation (commercial, academic
or government).

§  NormFlow For any large manufacturing company or utility.

§  ProfileFlow For any large information- based organisation or governmental department

(Corporate Yellow Pages/skills & experience memory).

§  XFlow combined with Customisation Toolkit plus TermFlow PolyDoc’s latest generation
base software to fulfil business partner aspirations in both specific industry sectors and in
a generic manner for Systems Integrator companies.

§  QuickScan & Detector PolyDoc’s methods & tools for inventory of processes,

preliminary valuation of knowledge assets and indication of potential improvements and
savings.

PolyDoc aims to grow through its own and business partner marketing efforts in the United
Kingdom, USA and Benelux and elsewhere predominantly through business partnerships. It
is anticipated that a significant contribution to longer term growth will be received through
a strategic alliance with a large global partner.

Research & Development

In the area of information and language technology PolyDoc continues to invest in research
to  ensure  the  Company’s  products  and  core  software  remain  at  the  leading  edge  of  proven
technologies.  This  includes  the  ITMC  research  project  being  partly  funded  by  Eureka.  In
addition  to  the  application  products  mentioned  above  further  products  are  planned  to  be
developed together with business partners through a customer- and market-driven approach.

19

        
        
Year 2000

As  is  well  known,  many  computer  and  digital  storage  systems  express  dates  using  only  the
last two digits of the year and will thus require modification or replacement to accommodate
the  year  2000  and  beyond.  This  is  a  complex  and  pervasive  issue.  The  operation  of  our
business  depends  not  only  on  our  own  products  and  computer  platforms,  operating  systems
and  application  software,  but  also  to  some  degree  on  those  of  our  suppliers,  customers  and
business partners. Given this complexity, it is not possible for any organisation to guarantee
that no year 2000 problems will arise. We have investigated the risks to our business resulting
from  the  date  change  to  the  year  2000,  and  have  developed  prioritised  action  plans  to  deal
with the key risks. PolyDoc’s own products have been developed with year 2000 compliance
in mind. With regard to our hardware platforms, operating systems and application software,
the Board believes that the group will have achieved an acceptable state of readiness and also
believes  that  it  will  be  able  to  deal  promptly  with  significant  failures  or  issues  that  might
arise.

The Board is satisfied that the total cost of modifications to the group’s systems and products
will not be significant.

20

        
        
DIRECTORS AND THEIR INTERESTS

The directors during the year and at 31 December 1998 and their interests in the share capital
of the Company (all beneficially held except those marked with an asterisk, * which are held
as trustee), were as follows:( the changes between S.A. Silcock’s beneficial and non-benficial
holdings relate to his children being over 18)

Ordinary Shares 
31 December
1998

Number of 

1 January
1998

Share Options
31 December
1998

Director

8.337.800
B. K. Mence
25.000
R. V. Maddocks
H. J. M. Rutten
507.500
E. R. E. I. Wiebenga 340.000
H. Coltof
S. A. Silcock
S. A. Silcock
D.C. Geest

-
192.450
107.010*
-

8.337.800
25.000
507.500
340.000
-
204.150
95.310*
-

-
400.000
-
-
100.000
-
-
-

1 January
1998

-
400.000
-
-
100.000
-
-
-

Of the 8.337.800 Ordinary Shares mentioned above B. K. Mence beneficially owns and is the
registered holder of 4.490.000 Ordinary Shares and he is, or his wife or children are, potential
beneficiaries  under  trusts  holding  an  aggregate  of  3.847.800  Ordinary  Shares  representing
20.56% of the voting rights of which trusts directors of Lawfords Ltd., in the Isle of Man, are
trustees  and  are  registered  as  the  holders  of  such  shares.  S.A.  Silcock  is  a  shareholder  in
Lawfords Ltd. in the Isle of Man. An Extraordinary General Meeting of the Company held on
28 July 1998, approved the subscription  by B.K. Mence for £ 523.640 5% Convertible Loan
Stock  at  par  and  to  subscribe  on  or  before  31  December  2000  to  Warrants  for  300.000
Ordinary Shares at £ 1.46 per share. If not exercised by that date the Warrants shall lapse.

On  28  July  1998,  the  Company  issued  £1,570,920  5%  Convertible  Loan  Stock  1999
(“Convertible Loan Stock”). £523,640 of the Convertible Loan Stock was subscribed for by
Barry  Mence  following  independent  shareholders’  approval  as  required  by  The  Panel  on
Takeovers  &  Mergers  (“the  Panel”).    Following  agreement  between  the  Company  and  the
Loan Stockholders, including Barry Mence, the redemption date and the conversion date for
the Convertible Loan Stock has been moved from 31 July 1999 to 31 July 2000 save that the
extension of the conversion date for the Convertible Loan Stock held by Barry Mence from
31 July 1999 to 31 July 2000 is subject to independent shareholders’ approval. Because the
extension  in  the  conversion  date  for  the  Convertible  Loan  Stock  held  by  Barry  Mence  is  a
variation  of  the  terms  of  the  Convertible  Loan  Stock  acquired  by  Barry  Mence  which  were
approved  at  the  shareholders  meeting  on  28  July  1998,  the  Panel  requires  that  shareholders
permission be sought for this variation.

The notice of annual general meeting accompanying this report includes a resolution to that
effect  which  must  be  approved  by  over  50%  of  the  votes  cast  on  a  poll  on  which  poll  the
shares  held  by  Barry  Mence  or  in  which  he  is  interested  will  not  be  voted.  The  Panel  has
required that shareholders be provided with the following information:

21

        
        
The minimum price per Ordinary Share at which conversion of the Convertible Loan Stock
can take place is 20p, (the nominal value of the Ordinary Shares). While the Directors (other
than Barry Mence) consider that it is extremely unlikely that this would occur, Barry Mence’s
maximum potential holding of Ordinary Shares would be as illustrated below. If Barry Mence
converted  all  his  Convertible  Loan  Stock  at  20p  per  share  and  subscribed  all  his  Warrants
(details of which were set out in the Circular to shareholders of 10 July 1998 (“the Circular”)
and neither of the other holders of Convertible Loan Stock converted any of their Convertible
Loan  Stock  or  subscribed  any  of  their  Warrants,  his  interests  in  the  Ordinary  Shares  would
increase to 50.87%.

The table below illustrates Barry Mence’s maximum potential interests in Ordinary Shares on
this basis.

Total Issued
Share Capital

No.

Barry Mence
Interests
in Ordinary
Shares
No.

%

19.208.885

8.337.800

43.41

Ordinary Shares in issue
at the date of this document

Maximum number of Ordinary Shares
which potentially may be issued to
Barry Mence on conversion

Conversion of Convertible Loan Stock
at 20p per share 

2.618.200

2.618.200

Warrant subscription

300.000

300.000

Ordinary Shares in issue on this basis

22.127.085

11.256.000

50.87

Shareholders are advised that, should Barry Mence’s interests in the Ordinary Shares exceed
50%,  Barry  Mence  would  be  free  to  increase  his  interests  in  the  Ordinary  Shares  further
without incurring any obligation under Rule 9 of the City Code on Takeovers and Mergers to
make a general offer to shareholders.

Neither Barry Mence nor his family trusts has dealt in the Ordinary Shares during the period
12 months before the date of posting of these Report and Accounts. There are no agreements,
arrangements or understandings (including any compensation arrangements) existing between
Barry Mence and any of the Directors, shareholders or recent shareholders of the Company
having  any  connection  with  or  dependence  upon  these  proposals.  There  are  no  agreements,
arrangements or understandings pursuant to which any securities acquired by Barry Mence as
a result of these proposals will be transferred to any other persons.

The mid market  prices  of the Ordinary  Shares as derived  from  the  London  Stock  Exchange
Daily Official List on the first dealing day of each of the six months immediately before the
date of this Report and Accounts and on the last practicable date prior to the publication of
this document, were are follows:

22

        
        
 
Date
1 December 1998
4 January 1999
1 February 1999
1 March 1999
1 May 1999
4 May 1999 
24 May 1999

Mid price
145 p
1421(cid:31)2
1571(cid:31)2
1471(cid:31)2
1521(cid:31)2
1611(cid:31)2
172 p

p
p
p
p
p

The  change  in  the  redemption  and  conversion  date  for  the  Convertible  Loan  Stock  was
effected by an Extraordinary Resolution in writing dated 12 April 1999 of all the holders of
the Convertible Loan Stock agreed to by the Company. The resolution was passed pursuant to
the  power  given  by  the  Convertible  Loan  Stock  Instrument  to  a  meeting  of  holders  of  the
Convertible Loan Stock, or written resolution in place thereof, to assent to any modification
or  abrogation  of  the  provisions  contained  in  the  conditions  set  out  in  that  instrument  or  to
which the Convertible Loan Stock is subject proposed or agreed to by the Company.

No changes other than those set out above have been made to the Convertible Loan Stock.

Copies  of  the  agreement  dated  22  June  1998  for  the  subscription  of  the  Convertible  Loan
Stock,  the  Convertible  Loan  Stock  Trust  Instrument,  the  Circular  and  the  Extraordinary
Resolution changing the redemption and conversion date to 31 July 2000 will be available for
inspection at the registered office of the company, 18 Southampton Place London WC1A 2AJ
from  the  posting  of  these  Report  and  Accounts  to  shareholders  until  the  conclusion  of  the
Annual General Meeting.

The options granted to R.V. Maddocks and H.Coltof on 28 August 1996, are at an exercise
price  of  20  p  per  share  exercisable  at  any  time  before  17  July  2001.  The  midmarket  share
price ranged from 117.50p to 297.50p during the financial year.

(b)  Save  as  disclosed  above,  no  Director  (or  member  of  his  family)  or  connected  persons
within the meaning of Section 346 of the Companies Act 1985 has any interest, beneficial or
non-beneficial, in the share capital of the company.

Substantial Shareholdings

The Directors are aware of the following persons who as at 24 May 1999 are interested
directly or indirectly in three per cent or more of the company’s issued Ordinary Shares:

Name

Brandon Limited
NPM Capital NV

No. of % issued
Ordinary Shares 
1.633.647
1.365.649

Ordinary Shares
8.50 %
7.11 %

In addition, as set out in paragraph (a) above, B. K. Mence and members of his family have
interests in 8.337.800 Ordinary Shares (43.41%).

23

        
        
Share Option Schemes

PolyDoc  Plc  Share  Option  Schemes:  On  28  August  1996  the  Directors  adopted  and  the
company  in  general  meeting  approved  a  share  option  scheme  to  provide  for  the  grant  to
certain directors and employees of PolyDoc NV of options over Ordinary Shares in exchange
for  the  surrender  by  such  directors  and  employees  of  their  existing  options  over  shares  in
PolyDoc  NV  and  to  provide  for  the  grant  by  the  company  of  subsequent  new  options  over
Ordinary Shares to employees of the Group.

Contracts

Service  contracts  between  the  company  and  the  executive  directors  are  terminable  on  6
months notice.

Creditor payment policy and practice

It  is  the  company’s  policy  that  payments  to  suppliers  are  made  in  accordance  with  those
terms and conditions agreed between the company and its suppliers, provided that all trading
terms and conditions have been complied with. At 31 December 1998, the company had an
average of 63 days purchases outstanding in trade creditors.

Auditors

A resolution to reappoint Ernst & Young as auditors will be put to the members at the Annual
General Meeting.

Approved by the Board on 27 May 1999.

E.R.E.I. Wiebenga
Secretary

24

        
        
REPORT ON DIRECTORS’ REMUNERATION

The  remuneration  committee  of  PolyDoc  Plc  is  responsible  for  determining  the  contract
terms, remuneration and other benefits for executive directors, including performance related
bonus schemes. The committee comprises the non-executive directors. It is chaired by Hans
Coltof. The details of directors’ interests in options is set out in the Directors’ Report.

The fees and emoluments of all directors are as follows:

Description

Fees
Other emoluments
Basic remuneration
Benefits
Pension contributions

1998
1997
£’000 £’000

19
29
238
47
15

18
29
243
46
15

348

351

Executive directors:

The emoluments of the executive directors for the financial year are as follows:

Barry Mence
1997
1998
£
£
68.412
67.721
11.510
11.409
79.922
79.130
4.200
3.600

Richard Maddocks

1998
£
79.137
15.729
94.866
6.975

1997
£
81.264
14.842
96.106
7.221

Huub Rutten
1997
1998
£
£
60.947
59.352
11.261
11.866
72.208
71.218
2.500
2.739

Iljitsj Wiebenga
1997
1998
£
£
32.507
31.655
8.156
8.198
40.663
39.853
1.500
1.461

82.730

84.122

101.841

103.327

73.957

74.708

41.314

42.163

Basic salary
Benefits
Subtotal
Pension
contributions
Total

Pension contributions are to a defined contribution scheme.

The basic salaries have remained unchanged. The lower emoluments in 1998 are caused by
differences in exchange rates.

25

        
        
Non executive directors:
The fees of the non executive directors for the year are as follows:

1997
£

Hans Coltof
1997
1998
£
£
6.300 6.564
-
6.300 6.564
The basic fees have remained unchanged. Certain of the other emoluments in 1998 are lower
due to differences in exchange rates.

Stuart Silcock 
1998
£
6.392 6.564
28.629 29.221
35.021 35.785

David Geest
1997
1998
£
£
6.272 5.079
-
6.272 5.079

Fees
Other emoluments
Total

-

-

The  emoluments  of  Hans  Coltof  (  in  1997)  and  Stuart  Silcock  were  paid  to  Van  der  Bunt
Management Consultants and Lawfords Limited, Chartered Accountants, of which they are a
partner and director respectively.

Service contracts

Details of the directors’ service contracts are given in the Directors’ Report.

26

        
        
 
 
STATEMENT OF DIRECTORS’ RESPONSIBILITIES

Statement of Directors’ responsibilities in respect of the accounts

Company law requires the directors to prepare accounts for each financial year which give a
true and fair view of the state of affairs of the company and of the group and of the profit or
loss  of  the  group  for  that  year.  In  preparing  those  accounts,  the  directors  are  required  to:

§  select suitable accounting policies and then apply them consistently;
§  make judgements and estimates that are reasonable and prudent;
§  state whether applicable accounting standards have been followed, subject to any material

departures disclosed and explained in the accounts;

§  prepare the accounts on a going concern basis unless it is inappropriate to presume that

the company will continue in business;

The directors confirm that they have complied with the above requirements in preparing the
accounts. The directors are responsible for keeping proper accounting records which disclose
with  reasonable  accuracy  at  any  time  the  financial  position  of  the  company  and  to  enable
them  to  ensure  that  the  accounts  comply  with  the  Companies  Act  1985.  They  are  also
responsible for safeguarding the assets of the company and hence for taking reasonable steps
for the prevention and detection of fraud and other irregularities.

27

        
        
GROUP PROFIT AND LOSS ACCOUNT

Group profit and loss account
For the year ended 31 December 1998

Notes

2

Turnover
Cost of sales

Gross loss
Sales and Marketing expense
Administrative expense
Other operating income -
foreign exchange gains

Operating loss
Bank interest receivable
Interest payable and similar charges 5

3(a)

1998
£’000

891
(892)

(1)
(502)
(468)

29

(942)
13
(52)

1997
£’000

241
(993)

(752)
(484)
(467)

136

(1.567)
46
(6)

Loss on ordinary activities
before and after taxation

Loss per share-basic and
diluted (pence)

(981)

(1.527)

8

(5.2p)

(8.2p)

28

        
        
GROUP STATEMENT OF TOTAL RECOGNISED GAINS AND LOSSES

1998
£’000

(981)
47

(934)

1998
£’000

261
(934)

167
15
-
 (491)

1997
£’000

(1.527)
(170)

(1.697)

1997
£’000

1.059
(1.697)

991
-
(92)
261

Group statement of total recognised gains and losses

Description

Loss on ordinary activities after taxation
Exchange difference on retranslation of net assets
of subsidiary undertakings
Total recognised gains and losses relating to the year

Reconciliation of shareholders’ funds

Description

Shareholders’ funds at 1 January
Total recognised gains and losses in year

Other movements:

New shares issued (including share premium)
Shares to be issued
Share issue costs
Shareholders’ funds at 31 December
(all equity interests)

29

        
        
At 31 December 1998

Fixed assets

Intangible assets
Tangible assets

Current assets

Debtors
Cash at bank and in hand

Creditors: amounts falling
due within one year

Net current assets/(liabilities)

Total assets less current liabilities

Creditors: amounts falling due
after more than one year

Capital and reserves
Called up share capital
Shares to be issued
Share premium account
Profit and loss account

Shareholders’ funds
(all equity interests)

Barry K. Mence
Executive Chairman
27 May 1999

GROUP BALANCE SHEET

Notes

1998
£’000

1997
£’000

540
203
743

127
674

801

2.032

(1.231)

(488)

3

(491)

3.773
15
2.213
(6.492)

192
223
415

104
434

538

375

163

578

317

261

3.743
-
2.076
(5.558)

(491)

 261

9
10

12

14

15

17
18
18
18

30

        
        
COMPANY BALANCE SHEET

At 31 December 1998

Notes

1998
£’000

1997
£’000

11

12

14

17
18
18
18

Fixed assets

4.777

2.820

Investments

2.737
95

2.832

1.613
1.219

5.996

3.773
15
2.213
(5)

5.996

3.017
-

3.017

23
2.994

5.814

3.743
-
2.076
(5)

5.814

Current assets

Debtors
Cash at bank and in hand

Creditors: amounts falling due within one year.
Net current assets

Total assets less current liabilities

Capital and reserves

Called up share capital
Shares to be issued
Share premium account
Profit and loss account

Shareholders’ funds (all equity interests)

Barry K. Mence
Executive Chairman
27 May 1999

31

        
        
GROUP STATEMENT OF CASH FLOWS

For the year ended 31 December 1998

Notes

Net cash outflow from operating activities

3(b)

Return on investments and servicing of finance
Interest received
Interest paid
Interest element of finance lease rental payments

Capital expenditure and financial investment

Payments to acquire intangible fixed assets
Payments to acquire tangible fixed assets

Acquisitions and disposals

Purchase of subsidiary undertaking
Net cash acquired with subsidiary undertaking

1998
£’000

(699)

13
(50)
(2)

(39)

(247)
(52)

(299)

(95)
2

(93)

1997
£’000

(1.547)

46
(4)
(2)

40

(107)
(131)

(238)

-
-

-

Management of liquid resources

(Increase)/decrease in short term deposits

(401)

803

Net cash outflow before financing

(1.531)

(942)

Financing

Issue of ordinary share capital
Share issue costs
New long term loan
Repayment of long term loan
Repayment of capital element of finance lease

(Decrease)/increase in cash

32

110
-
1.571
(299)
(12)

1.370

(161)

991
(92)
336
-
(19)

1.216

274

        
        
NOTES TO THE ACCOUNTS

1. Accounting policies

Accounting convention
The  accounts  are  prepared  under  the  historical  cost  convention  and  in  accordance  with
applicable accounting standards.

Basis of consolidation
The consolidated accounts include the results of the company and its subsidiary undertakings.
The excess of the cost of acquisition of Lessenger Associates BV over its net asset value has
been  included  as  goodwill  under  intangible  fixed  assets.  The  acquisition  of  PolyDoc  NV  in
1996  was  accounted  for  as  a  merger  under  the  provisions  of  Financial  Reporting  Standard
No. 6.

Tangible fixed assets
Tangible  fixed  assets  are  stated  at  historical  cost,  less  accumulated  depreciation.  Tangible
fixed  assets  are  depreciated  on  a  straight  line  basis  at  20%  per  annum  on  cost  over  their
expected useful lives.

Research and development
Research  and  development  expenditure  is  written  off  as  incurred,  except  that  development
expenditure incurred for a specific product is capitalised as an intangible asset when its future
recoverability can reasonably be regarded as assured. The assets are amortised on a straight
line basis over their estimated useful economic life which is currently estimated to be 5 years.
The registration expenses of patents and trademarks are written off as incurred.

Grants and subsidies
Certain  development  projects  benefit  from  a  European  funding  programme  which  makes
subsidy payments on the basis of six-monthly returns. Grants and subsidies are credited to the
profit and loss account so as to match with the expenditure to which they relate.

Goodwill
Goodwill arising on consolidation is capitalised and amortised on a straight line basis over its
estimated useful economic life up to a presumed maximum of 20 years. The goodwill arising
on  the  acquisition  of  Lessenger  Associates  BV  during  the  year  is  being  amortised  over  10
years. Goodwill is reviewed for impairment at the end of the first full year financial year after
acquisition  and  in  other  periods  if  events  or  changes  in  circumstances  indicate  that  the
carrying value may not be recoverable.

Long term contracts
Profit on long-term contracts is taken as the work is carried out if the final outcome can be
assessed  with  reasonable  certainty.  The  profit  included  is  calculated  on  a  prudent  basis  to
reflect  the  proportion  of  the  work  carried  out  at  the  year  end,  by  recording  turnover  and
related costs as contract activity progresses. Turnover is calculated as that proportion of total
contract  value  which  costs  incurred  to  date  bear  to  total  expected  costs  for  that  contract.
Revenues  derived  from  variations  on  contracts  are  recognised  only  when  they  have  been
accepted  by  the  customer.  Full  provision  is  made  for  losses  on  all  contracts  in  the  year  in
which they are first foreseen.

33

        
        
Deferred taxation
Deferred  taxation  is  provided  using  the  liability  method  on  all  timing  differences,  including
those  relating  to  pensions  and  other  post  retirement  benefits,  to  the  extent  that  they  are
expected to reverse in the future without being replaced, calculated at the rate at which it is
anticipated the timing differences will reverse.

Foreign currencies
Company: Transactions in foreign currencies are recorded at the rate ruling at the date of the
transaction  or  at  the  contracted  rate  if  the  transaction  is  covered  by  a  forward  exchange
contract. Monetary assets and liabilities denominated in foreign currencies are retranslated at
the rate of exchange ruling at the balance sheet date or if appropriate at the forward contract
rate. All differences are taken to the profit and loss account. Group: The assets and liabilities
of the subsidiary undertaking are translated at the rate of exchange ruling at the balance sheet
date. The profit and loss account is translated at the average rate of exchange. The exchange
difference  arising  on  the  retranslation  of  the  subsidiary  undertaking  is  taken  directly  to
reserves. All other translation differences are taken to the profit and loss account.

Pensions
PolyDoc contributes to the personal pension arrangements of certain employees, the costs of
which are charged in the profit and loss account as incurred.

Leasing
Assets held under finance leases, which are leases where substantially all risks and rewards of
ownership of the assets have passed to the group are capitalised in the balance sheet and are
depreciated over their useful lives. The capital elements of future obligations under financial
leases  are  included  as  liabilities  in  the  balance  sheet.  The  interest  elements  of  the  rental
obligations are charged to the profit and loss account over the periods of the financial lease
and represent a constant proportion of the balance of capital repayments outstanding. Rentals
payable  under  operating  leases  are  charged  in  the  profit  and  loss  account  on  a  straight  line
basis over the lease term.

2. Turnover and segmental information

Turnover (excluding valued added tax) represents the amounts derived from the provision of
services  and  software  supplied  which  fall  within  the  group’s  ordinary  activities.  The  group
operates  in  one  principal  area  of  activity,  that  of  the  design  of  software  systems  and  the
development, production and marketing of software products and methodologies. It operates
within three geographical markets, the Benelux, the United Kingdom and the United States of
America.

34

        
        
An analysis of turnover by destination is given below:

1998
£’000

 722
166
 3
891

1997
£’000

93
111
37
241

Description

The Benelux
United Kingdom
United States of America

An analysis of turnover, loss on ordinary activities,
before taxation, and net assets by source is as follows:

1998
£’000
The Netherlands

1997
£’000
The Netherlands

Description

 891
(981)
(491)

241
(1.527)
284

Turnover
Loss on ordinary activities before taxation
Net assets/(liabilities)

The  United  Kingdom  has  no  turnover  by  source  or  losses  on  ordinary  activities  before
taxation,  and  had  net  liabilities  of  £  nil  (1997:  £23.000)  by  source.  The  United  States  of
America has no turnover by source or losses on ordinary activities before taxation or any net
liabilities (1997: £ nil).

3. Operating Loss

(a) This is stated after charging/(crediting)

1998
£’000

 20
 1.197
 66
(304)
(29)
 63
 9
 94
 79

1997
£’000

26
1.155
23
(162)
(136)
60
7
67
83

Description

Auditors’ remuneration - audit services *
Research and development expenditure written off
Amortisation of deferred development expenditure
Eureka subsidies
Foreign exchange gains
Depreciation of owned assets
Depreciation of assets held under finance leases
Operating lease rentals - land and buildings
Operating lease rentals - motor vehicles

*£ 8.915 (1997: £ 6.000) of this relates to the company.

In  the  view  of  the  directors,  the  turnover  and  operating  loss  of  Lessenger  Associates  BV,
since  acquisition  on  3  December  1998  is  not  material  for  the  purpose  of  analysing  the
performance of continuing operations between acquisitions and other.

35

        
        
 
 
 
 
 
(b) Reconciliation of operating loss to net cash outflow from operating activities

1997
£’000

(1.567)
60
23
9
8
107
(14)
(173)
(1.547)

Operating loss
Depreciation
Amortisation
Intangible Fixed assets written off
Loss on disposal of Tangible Fixed Assets
decrease in debtors
Increase/(decrease) in creditors and provisions
Exchange movements
Net cash outflow from operating activities

4. Staff Costs

Wages and salaries
Social security costs
Other pension costs

1998
£’000
857
74
29

960

1998
£’000

(942)
72
66
-
-
9
50
46
(699)

1997
£’000
923
40
23

986

The directors’ emoluments are disclosed in the Report on Directors’ Remuneration on
page 22.

The average monthly number of employees during the year was made up as follows:

Full time employees
Contracted employees

1998
Number

1997
Number

25
6

31

25
5

30

5. Interest Payable and Similar Charges

Bank loans and overdrafts
Convertible loan stock
Finance charges on finance leases

1998
£’000

1997
£’000

16
34
2

52

4
-
2

6

36

        
        
6. Taxation

There  was  no  tax  charge  during  the  year  (1997:£  nil).  Tax  losses  are  available  for  carry
forward by the Group the amount of which is under discussion with the relevant authorities in
the  UK  and  The  Netherlands.  In  accordance  with  the  group’s  policy  no  provision  has  been
made for the potential deferred tax asset on these losses.

7. Loss attributable to members of the parent company

The  loss  dealt  with  in  the  accounts  of  the  parent  company  for  1998  was  nil  (1997:£  nil).
Advantage has been taken of Section 230 of the Companies Act 1985 not to present a profit
and loss account for the parent company.

8. Loss Per Ordinary Share

The calculation of basic loss per ordinary share is based on a loss, of £ 981.000 (1997:
£ 1.527.000), and 18.730.633 (1997: 18.652.691) ordinary shares, being the weighted average
number  of  ordinary  shares  in  issue  during  the  year.  All  potential  ordinary  shares  are
antidilutive.

9. Intangible Fixed Assets

Goodwill 

£’000

Development 
costs
£’000

-
-
167
167

-
-
-

-

167

-

214
25
227
466

22
5
66

93

373

192

Total

£’000

214
25
394
633

22
5
66

93

540

192

Group

Cost
At 1 January 1998
Exchange adjustments
Additions
At 31 December 1998

Amortisation
At 1 January 1998
Exchange adjustments
Provided during the year

Net book value
At 31 December 1998

At 31 December 1997

Goodwill arising on the acquisition of Lessenger Associates BV is being amortised evenly
over the directors’ estimate of its useful life of 10 years.

37

        
        
10. Tangible Fixed Assets

Group

Computer 
equipment
£’000

Furniture and 
fittings
£’000

Total

£’000

Cost
At 1 January 1998
Exchange adjustment
Additions
Disposals
At 31 December 1998

Depreciation
At 1 January 1998
Exchange adjustments
Provided during the year
Disposals
At 31 December 1998

Net book value
At 31 December 1998
At 31 December 1997

227
17
38
-
282

92
7
50
-
149

133
135

110
 7
-
-
117

22
3
22
-
47

70
88

337
24
38
-
399

114
10
72
-
196

203
223

The net book value of furniture and fittings above includes an amount of £ 27.000
(1997: £ 36.000) in respect of assets held under finance leases. Other than those
held under finance leases, fixed assets are free and unencumbered.

11. Investments

Company

Investment in
subsidiary undertakings
£’000

Cost
At 31 December 1997
Additions
At 31 December 1998

2.820
1.957
4.777

On 18 May 1998 the company acquired a further 1.200.000 shares in its subsidiary company,
PolyDoc NV for a consideration of £ 1.790.000 satisfied by setting off the obligation to pay
part of the intercompany balances.

On  3  December  1998  the  group  acquired  Lessenger  Associates  BV  for  consideration  of  £
168.000,  satisfied  by  the  payment  in  cash  of  £  95.000,  and  by  the  issue  of  40.000  ordinary
shares  of  20p  each.  A  further  10.000  ordinary  shares  of  20p  may  be  issued  as  additional
consideration in the next 12 months if certain conditions are met. In the view of the directors
the  additional  consideration  will  be  payable  and  accordingly  it  has  been  provided  for  as
shares to be issued at £1.46, the market price on the date of the acquisition.

38

        
        
Goodwill arising on the consolidation of Lessenger Associates BV has been included in the
consolidated  balance  sheet  and  is  being  amortised  over  the  directors’  estimate  of  its  useful
life of 10 years.

Analysis of the acquisition of Lessenger Associates BV:

Book value Company
£’000

Debtors
Cash

Creditors falling due within one year

Net assets
Goodwill arising on acquisition

Discharged by:
Fair value of shares issued
Shares to be issued
Cash

32
2

34

33

1
167

168

58
15
95

168

Lessenger  Associates  BV  made  a  loss  after  tax  of  £1.000  in  the  year  ended  31  December
1998  (1997  -  £  700).  There  was  a  profit  of  £2.500  in  the  period  1  January  1998  to  3
December 1998.

Details  of  the  investments  in  which  the  group  or  company  holds  more  than  20%  of  the
nominal value of any class of share capital are as follows:

Name of company Country of
registration
(or incor-
poration)
and operation

Holding

          Nature of

Proportion
of voting rights        business
and of business

PolyDoc NV

The 
Netherlands

Ordinary 
shares

100%

Lessenger
Associates BV

The 
Netherlands

Ordinary
shares

100%          

         Knowledge
         Management
         Software
         developer

         Document
         Management
         Software
         supplier

39

        
        
        
           
12. Debtors

Description

Trade debtors
Amounts owed by subsidiary undertakings
Other debtors
Prepayments and accrued income

Trade debtors are free and unencumbered.

Group
1998
1997
£’000 £’000

72
85
-
-
-
-
42        32        

Company
1998
1997
£’000 £’000

-

-
2.737 3.017
-
-
-           -           

127

104

2.737 3.017

13. Net debt

(a) Reconciliation of net cash flow to movement in net debt

(Decrease)/increase in cash
Repayment of long term loans
Cash inflow from increase in debt 
Repayments of capital elements of finance leases
Cash (inflow)/ outflow from change in liquid resources
Change in net debt resulting from cash flows
Exchange differences
Other

1998
£’000

(161)
299
(1.571)
12
401
(1.020)
-
-

(1.020)
103
(917)

1997
£’000

274
(336)
-
19
(803)
(846)
37
(51)

(860)
963
103

Movement in net debt
Net debt at 1 January
Net debt at 31 December 

(b) Analysis of net debt

Cash at bank
Liquid resources
New long term loan
Convertible loan stock
Finance leases

1 January 
1998
£’000

433
1
(299)
-
(32)      

Cashflow

£’000

(161)
401
299
(1.571)
12        

31 December
1998
£’000

272
402
-
(1.571)
(20)      

103

(1.020)

(917)

Liquid resources are included within cash at bank and in hand on the balance sheet.

40

        
        
 
14. Creditors: amounts falling due within one year

Company
1998
£’000

1.571
-
-
2
40        

1997
£’000

-
-
-
8
15        

Group
1998
£’000

1.571
17
306
25
113      

1997
£’000

   5% Convertible loan stock
   Obligations under finance leases
   Trade creditors
   Other taxes and social security costs

-
14
226
45
90           Accruals

1.613

23

2.032

375

The 5% Convertible loan stock was issued to the company’s three largest shareholders on 31
July  1998  and  was  repayable  or  convertible  into  ordinary  shares  at  a  conversion  price  of  £
1.46 on 31 July 1999,at the option of the loan stockholders. Interest on the Convertible Loan
Stock  is  payable  on  30  June  and  31  December.  On  12  April  1999,  the  repayment  or
conversion was extended to 31 July 2000 as disclosed in note 20. The amount of £ 1.571.000
is  thus  included  in  current  liabilities  at  31  December  1998,  although  it  became  an  amount
falling due after more than one year on 12 April 1999.

15. Creditors: amounts falling due after more than one year

Company
1998
£’000

-
-           

1997
£’000

-
-           

Group
1998
£’000

-
3          

1997
£’000    Bank loan falling due between one and

    two years

299
18           Obligations under finance leases 

-

-

3

317

The bank loan had an interest rate of 6%, and was repaid on 31 July 1998.

16. Obligations under leases

Amounts due under finance leases and hire purchase contracts:

1998
£’000

17
4
21
1          

1997
£’000

16
19
35
3          

20

32

Group

Amounts payable:
Within one year
In two to five years

Less finance charges allocated to future periods

41

        
        
The  company  had  no  amounts  due  under  finance  leases  and  hire  purchase  contracts.  At  31
December  1998 the  group had annual  commitments under operating  leases as  set out  at the
top of the next page:

Group

l

Operating leases which expire 

other
1998
£’000

and &
buildings
1998
£’000

other
1997
£’000

land &
buildings
1997
£’000

within one year
in two to five years

26
63        

-
100      

8
48        

-
91        

89

100

56

91

The company had commitments under operating leases as at 31 December 1998 amounting to
£4.000 (1997: £ nil ) expiring within one year and £12.000 expiring within two to five years
(1997: £16.000).

17. Share Capital

Company

Authorised
Equity:
Ordinary shares of 20p each at
31 December 1998 and 31 December 1997

Number

30.000.000

Allotted, called up and fully paid
Equity:
Ordinary shares of 20p each at 31 December 1997 18.715.385
Ordinary shares of 20p each at 31 December 1998 18.863.885

£’000

6.000

3.743
3.773

On 15 October 1998, 30.000 ordinary shares were issued for cash at 20p each. On 20 October
1998, 10.000 ordinary shares were allotted for cash to a holder of share options at 20p each.
On 9 December 1998 68.500 ordinary shares of 20p each were issued at £1.46 for cash and a
further 40.000 ordinary shares of 20p each were issued at £1.46 as part consideration for the
acquisition  of  Lessenger  Associates  BV.  As  described  in  note  11,  a  further  10.000  ordinary
shares will be issued to the vendors of Lessenger Associates BV if certain conditions are met.

An  Extraordinary  General  Meeting  of  the  Company  held  on  28  July  1998,  approved  the
subscription  by  each  of  B.K.  Mence,  NPM  Capital  NV  and  Brandon  Ltd,  of  £523.640  5%
Convertible Loan Stock at par the conversion terms of which are described in note 14, as well
as the award of 300.000 Warrants each. The Warrants did not attract any consideration. Each
Warrant  entitles  the  holder  to  subscribe  on  or  before  31  December  2000,  for  one  Ordinary
Share at £1.46 per share. If not exercised by that date the Warrants shall lapse.

42

        
        
Share option scheme

The company has specified a maximum of 900.000 ordinary shares over which options could
be granted under any employee share option scheme. During 1998, 80.000 options were not
taken up and became available for re-issue and 10.000 options were exercised at 20p. During
1998  the  company  has  granted  options  over  69.000  ordinary  shares  to  employees,  at  a
subscription price equal to the market price of 170p. at the date of the grant, leaving a balance
at  31  December  1998,  of  100.000  ordinary  shares  over  which  options  could  be  granted.
Options granted to directors are specified in the Directors’ Report. The balance of options are
held by employees. Share options are granted by the Board of directors on a
discretionary basis.

Options subsisting under the share option scheme at 31 December 1998 were:

Year options
granted

Number
of options

Exercise price
pence
per share

Period during
which options
exercisable

1996
1997
1998

660.000
71.000
69.000

20
64,5-197.5
170

1998-2006
2000-2007
2001-2008

18. Shareholders’ funds

Share
capital
£’000

3.743

30

-

-

Shares to be Share Premium
issued
£’000

Account
£’000

Profit and 
Loss Account
£’000

   Total    Group

   £’000

-

-

15

-

2.076

137

-

-

(5.558) 

   261     At 1

    January 1998

-

-

(981)

   15

   167     Arising on
    share issues
    Shares to
    be issued
    Retained loss
    for the year

(981)

-           

-           

-           

47        

47            Exchange

    differences on
retranslation of
net assets and
results of
subsidiary
    undertaking

   At 31
   December 1998

3.773

15

2.213

(6.492)

(491)

43

        
        
 
 
 
 
Dutch law requires that an amount equal to the net book value of the amounts capitalised in
respect  of  development  costs  be  transferred  from  the  profit  and  loss  reserve  to  a  non-
distributable  legal  reserve.  To  this  extent  £  373.000  (1997:  £  192.000)  of  PolyDoc  NV’s
profits (if available) would not be distributable as at 31 December 1998.

Shareholders’ funds
Company

At 31 December 1997 
Arising on share issues
Shares to be issued

Share Shares to be
capital issued
£’000 £’000
3.743 -
30
-
-           15                    -                       -                       15        

Share Premium Profit and 
Account
£’000
2.076
137

 Loss Account
 £’000
(5)
-

£’000
5.814
167

Total

At 31 December 1998

3.773 15

2.213

(5)

5.996

19. Contingent liabilities

Company
In accordance with Article 403, Paragraph 1, Subsection b, Book 2 of the Dutch Civil Code
(B.W.), PolyDoc Plc guarantees the liabilities of PolyDoc NV and agrees with the departure
from  the  regulations  in  Title  9  Book  2  of  the  Dutch  Civil  Code  (B.W.),  that  prescribes  the
submission  of  the  accounts  of  PolyDoc  NV  to  the  Trade  Register  in  The  Netherlands.  As  a
consequence PolyDoc NV need not file its accounts at the Trade Register.

20. Post Balance Sheet Events

On  20  January  1999,  a  further  5.000  ordinary  shares  were  allotted  for  cash  to  a  holder  of
share options at 20p each. On 12 March 1999, a further 340.000 ordinary shares were issued
for £ 499.800 in cash giving a share premium of £431.800.

On 12 April 1999, the repayment or conversion of the £ 1.570.920 Convertible Loan Stock
held  by  the  Company’s  three  largest  ordinary  shareholders,  was  extended  from  its  original
date of 31 July 1999 to 31 July 2000. This amount has been included in amounts falling due
within  one  year  at  31  December  1998.  Further  details  of  the  change  in  the  redemption  and
conversion date can be found in the Directors’ Report.

On 19 February 1999 Lessenger Associates BV changed its name to Lessenger BV.

44

        
        
AUDITORS’ REPORT TO THE SHAREHOLDERS OF POLYDOC PLC

We  have  audited  the  accounts  on  pages  25  to  41  which  have  been  prepared  under  the
historical cost convention and on the basis of the accounting policies set out on pages 30
and 31.

Respective responsibilities of directors and auditors

The directors are responsible for preparing the Annual Report including, as described on page
24, the accounts.  Our responsibilities, as independent auditors, are established by statute, the
Auditing  Practices  Board  and  by  our  profession’s  ethical  guidance.  We  report  to  you  our
opinion  as  to  whether  the  accounts  give  a  true  and  fair  view  and  are  properly  prepared  in
accordance with the Companies Act. We also report to you if, in our opinion, the directors’
report is not consistent with the accounts, if the group has not kept proper accounting records,
if we have not received all the information and explanations we require for our audit, or if the
information  specified  by  law  regarding  directors’  remuneration  and  transactions  with  the
company is not disclosed. We read the other information contained in the Annual Report and
consider whether it is consistent with the audited accounts. We consider the implications for
our report if we become aware of any apparent misstatements or material inconsistencies with
the accounts.

Basis of audit opinion

We  conducted  our  audit  in  accordance  with  Auditing  Standards  issued  by  the  Auditing
Practices  Board.  An  audit  includes  examination,  on  a  test  basis,  of  evidence  relevant  to  the
amounts  and  disclosures  in  the  accounts.  It  also  includes  an  assessment  of  the  significant
estimates  and  judgements  made  by  the  directors  in  the  preparation  of  the  accounts,  and  of
whether  the  accounting  policies  are  appropriate  to  the  group’s  circumstances,  consistently
applied and adequately disclosed. We planned and performed our audit so as to obtain all the
information  and  explanations  which  we  considered  necessary  in  order  to  provide  us  with
sufficient  evidence  to  give  reasonable  assurance  that  the  accounts  are  free  from  material
misstatement, whether caused by fraud or other irregularity or error. In forming our opinion
we also evaluated the overall adequacy of the presentation of information in the accounts.

Opinion

In  our  opinion  the  accounts  give  a  true  and  fair  view  of  the  state  of  affairs  of  the  company
and of the group as at 31 December 1998 and of the loss of the group for the year then ended
and have been properly prepared in accordance with the Companies Act 1985.

Ernst & Young
Registered Auditor
Reading

27 May 1999

45

        
        
POLYDOC PLC

Address:
‘De Gelder’
A.J. Ernststraat 595 - G
1082 LD Amsterdam

Telephone:
(+31) 20 - 301 39 00

Telefax:
(+31) 20 - 301 39 99

General E-mail address:
info@polydoc.com

Internet:
http://www.polydoc.com

46